• Je něco špatně v tomto záznamu ?

Selective coronary angiography, percutaneous coronary intervention and asymptomatic peri-procedural myocardial injury

M. Griva, J. Stastny, P. Kopriva, M. Slabak, Z. Coufal, J. Jarkovsky, M. Svoboda, T. Salek, L. Sukupova, M. Taborsky

. 2019 ; 163 (4) : 324-330. [pub] 20181106

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20010321

BACKGROUND: While there have been a number of studies reporting the incidence and implications of elevated troponin levels after percutaneous coronary intervention (PCI), the body of information about the incidence, associations, and implications of elevated troponin levels following coronary angiography (CAG) is limited. MATERIALS AND METHODS: A total of 220 consecutive patients with stable coronary artery disease or intermediate or low-risk acute coronary syndrome without persistent ST-segment elevation (NSTE-ACS) were included in our study. High-sensitivity cardiac troponin I (hs-cTnI) levels were measured before and after coronary angiography (CAG) in patients with or without PCI and correlated with a number of clinical variables. RESULTS: Hs-cTnI elevations above the 99th percentile upper reference limit (URL), or above 20% of the initially positive, yet already declining values, were found in 60 (37.2%) patients after CAG and in 45 (76.2%) patients undergoing PCI. Significant correlations of hs-cTnI elevation were found with the following variables: volume of contrast, fluoroscopy time, dose-area product, amount of contrast agent injected directly into the coronary arteries, total time of balloon dilation and the number and total length of implanted stents (P<0.001 for all). CONCLUSION: While an asymptomatic elevation of hs-cTnI is a common finding after PCI, it does occur, quite surprisingly, also after CAG. Despite contradictory views regarding the clinical relevance of asymptomatic post-procedural elevated hs-cTnI levels, it is generally believed that a mild elevation is not associated with an increased risk. Still, it may pose a diagnostic quandary following a successful interventional procedure and even more so after an uncomplicated CAG. TRIAL REGISTRATION: Clinicaltrials.gov - NCT02960321.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20010321
003      
CZ-PrNML
005      
20200811123454.0
007      
ta
008      
200707s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2018.066 $2 doi
035    __
$a (PubMed)30398220
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Gřiva, Martin, $d 1974- $7 xx0117258 $u Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
245    10
$a Selective coronary angiography, percutaneous coronary intervention and asymptomatic peri-procedural myocardial injury / $c M. Griva, J. Stastny, P. Kopriva, M. Slabak, Z. Coufal, J. Jarkovsky, M. Svoboda, T. Salek, L. Sukupova, M. Taborsky
504    __
$a Literatura
520    9_
$a BACKGROUND: While there have been a number of studies reporting the incidence and implications of elevated troponin levels after percutaneous coronary intervention (PCI), the body of information about the incidence, associations, and implications of elevated troponin levels following coronary angiography (CAG) is limited. MATERIALS AND METHODS: A total of 220 consecutive patients with stable coronary artery disease or intermediate or low-risk acute coronary syndrome without persistent ST-segment elevation (NSTE-ACS) were included in our study. High-sensitivity cardiac troponin I (hs-cTnI) levels were measured before and after coronary angiography (CAG) in patients with or without PCI and correlated with a number of clinical variables. RESULTS: Hs-cTnI elevations above the 99th percentile upper reference limit (URL), or above 20% of the initially positive, yet already declining values, were found in 60 (37.2%) patients after CAG and in 45 (76.2%) patients undergoing PCI. Significant correlations of hs-cTnI elevation were found with the following variables: volume of contrast, fluoroscopy time, dose-area product, amount of contrast agent injected directly into the coronary arteries, total time of balloon dilation and the number and total length of implanted stents (P<0.001 for all). CONCLUSION: While an asymptomatic elevation of hs-cTnI is a common finding after PCI, it does occur, quite surprisingly, also after CAG. Despite contradictory views regarding the clinical relevance of asymptomatic post-procedural elevated hs-cTnI levels, it is generally believed that a mild elevation is not associated with an increased risk. Still, it may pose a diagnostic quandary following a successful interventional procedure and even more so after an uncomplicated CAG. TRIAL REGISTRATION: Clinicaltrials.gov - NCT02960321.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a koronární angiografie $x škodlivé účinky $7 D017023
650    _2
$a nemoci koronárních tepen $x terapie $7 D003324
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a koronární angioplastika $x škodlivé účinky $x metody $7 D062645
650    _2
$a perioperační péče $x škodlivé účinky $7 D019990
650    _2
$a troponin $x krev $7 D014336
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šťastný, Jiří $7 xx0231094 $u Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic
700    1_
$a Kopřiva, Petr $7 xx0229429 $u Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic
700    1_
$a Slabák, Martin $7 xx0138108 $u Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic
700    1_
$a Coufal, Zdeněk, $d 1961- $7 xx0230466 $u Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic
700    1_
$a Jarkovský, Jiří, $d 1976- $7 stk2008461294 $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
700    1_
$a Svoboda, Michal $7 xx0230935 $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
700    1_
$a Šálek, Tomáš, $d 1974- $7 xx0174625 $u Department of Clinical Biochemistry, Tomas Bata Regional Hospital, Zlin, Czech Republic
700    1_
$a Súkupová, Lucie $7 xx0144800 $u Department of the Director, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Táborský, Miloš, $d 1962- $7 jn20010310074 $u Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 163, č. 4 (2019), s. 324-330
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30398220 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20200707 $b ABA008
991    __
$a 20200811123451 $b ABA008
999    __
$a ok $b bmc $g 1545962 $s 1100413
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 163 $c 4 $d 324-330 $e 20181106 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20200707

Najít záznam

Citační ukazatele

Možnosti archivace